"Nothing in this world is more powerful as an idea whose time has come." LC MED AG has a pharmaceutical wholesale license in accordance with §52a of the Medicines Act (AMG) and a permit to handle narcotics in accordance with §3 of the Act on Narcotics (BtMG) in Germany. The pathway for affordable cannabis therapy for people with serious illnesses in Germany has finally been opened up. In 2017, the German Bundestag adopted an amendment which made it much easier for patients to be prescribed medical cannabis and have the costs reimbursed by their health insurance companies. LC MED AG fully intends to become an active partner in this process, offering medicines with highest-quality cannabis and cannabis extracts as their active ingredient in accordance with our sustainable business philosophy. Patients and their health remains at the centre of everything we do. We find ourselves globally at a time of change. As legalisation moves across Europe as a whole, more and more people suffering from a whole range of illnesses are being given access to medicinal cannabis as a treatment alternative. It is our aim to drive this development, and to make up the current shortfall in our knowledge and supply of cannabinoids as medicines for affected patients. Thanks to the comprehensive expertise of our team in all related spheres and our business group’s wide international network, we bring together both the willingness and the capacity to follow this path.